UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 37

Sortiert nach

Characterization of plaque phenotypes exhibiting an elevated pericoronary adipose tissue attenuation: insights from the REASSURE-NIRS registry

The international journal of cardiovascular imaging, 2023-10, Vol.39 (10), p.1943-1952

2023

Volltextzugriff (PDF)

Clinical predictors and sequelae of computed tomography defined leaflet thrombosis following transcatheter aortic valve replacement at medium-term follow-up

Heart and vessels, 2021-09, Vol.36 (9), p.1374-1383

2021

Volltextzugriff (PDF)

ApoA-I Induction as a Potential Cardioprotective Strategy: Rationale for the SUSTAIN and ASSURE Studies

Cardiovascular drugs and therapy, 2012-04, Vol.26 (2), p.181-187

2012

Volltextzugriff (PDF)

How Will Our Practice Change After the CLEAR Outcomes Trial?

Current atherosclerosis reports, 2024-03, Vol.26 (3), p.83-89

2024

Volltextzugriff (PDF)

The New Face of Hyperlipidemia and the Role of PCSK9 Inhibitors

Current cardiology reports, 2019-04, Vol.21 (4), p.18-18, Article 18

Nicholls, Stephen J.

2019

Volltextzugriff (PDF)

CETP Inhibitors: Should We Continue to Pursue This Pathway?

Current atherosclerosis reports, 2022-12, Vol.24 (12), p.915-923

2022

Volltextzugriff (PDF)

Inflammation in Coronary Atherosclerosis and Its Therapeutic Implications

Cardiovascular drugs and therapy, 2022-04, Vol.36 (2), p.347-362

2022

Volltextzugriff (PDF)

The Riskier Lipid: What Is on the HORIZON for Lipoprotein (a) and Should There Be Lp(a) Screening for All?

Current cardiology reports, 2021-08, Vol.23 (8), p.97-97, Article 97

2021

Volltextzugriff (PDF)

Elevated HDL-bound miR-181c-5p level is associated with diabetic vascular complications in Australian Aboriginal people

Diabetologia, 2021-06, Vol.64 (6), p.1402-1411

2021

Volltextzugriff (PDF)

Assessing the Impact of Colchicine on Coronary Plaque Phenotype After Myocardial Infarction with Optical Coherence Tomography: Rationale and Design of the COCOMO-ACS Study

Cardiovascular drugs and therapy, 2022-12, Vol.36 (6), p.1175-1186

2022

Volltextzugriff (PDF)

PCSK9 Inhibitors: Treating the Right Patients in Daily Practice

Current cardiology reports, 2017-08, Vol.19 (8), p.66-66, Article 66

2017

Volltextzugriff (PDF)

Calcified plaque harboring lipidic materials associates with no-reflow phenomenon after PCI in stable CAD

The international journal of cardiovascular imaging, 2023-10, Vol.39 (10), p.1927-1941

2023

Volltextzugriff (PDF)

Lessons from Coronary Intravascular Ultrasound on the Importance of Raising High-Density Lipoprotein Cholesterol

Current atherosclerosis reports, 2010-09, Vol.12 (5), p.301-307

2010

Volltextzugriff (PDF)

CETP Inhibition in CVD Prevention: an Actual Appraisal

Current cardiology reports, 2016-05, Vol.18 (5), p.43-43, Article 43

2016

Volltextzugriff (PDF)

Evacetrapib

Current cardiology reports, 2012-06, Vol.14 (3), p.245-250

Nicholls, Stephen J.

2012

Volltextzugriff (PDF)

Update in Therapeutic Approaches to Plaque Stabilization

Current atherosclerosis reports, 2014-03, Vol.16 (3), p.392-392, Article 392

2014

Volltextzugriff (PDF)

The Distinctive Nature of Atherosclerotic Vascular Disease in Diabetes: Pathophysiological and Morphological Insights

Current diabetes reports, 2012-06, Vol.12 (3), p.280-285

2012

Volltextzugriff (PDF)

Atherosclerosis regression: is low-density lipoprotein or high-density lipoprotein the answer?

Current atherosclerosis reports, 2007-10, Vol.9 (4), p.266-273

2007

Volltextzugriff (PDF)

Apo A-I Modulating Therapies

Current cardiology reports, 2011-12, Vol.13 (6), p.537-543

Nicholls, Stephen J.

2011

Volltextzugriff (PDF)

Inhibition of secretory phospholipase A(2) in patients with acute coronary syndromes: rationale and design of the vascular inflammation suppression to treat acute coronary syndrome for 16 weeks (VISTA-16) trial

Cardiovascular drugs and therapy, 2012-02, Vol.26 (1), p.71-75

2012

Volltextzugriff (PDF)

Statin Effects on Both Low-Density Lipoproteins and High-Density Lipoproteins: Is There a Dual Benefit?

Current atherosclerosis reports, 2010, Vol.12 (1), p.14-19

2010

Volltextzugriff (PDF)

Study Design, Rationale, and Baseline Characteristics: Evaluation of Fenofibric Acid on Carotid Intima-Media Thickness in Patients with Type IIb Dyslipidemia with Residual Risk in Addition to Atorvastatin Therapy (FIRST) Trial

Cardiovascular drugs and therapy, 2012-08, Vol.26 (4), p.349-358

2012

Volltextzugriff (PDF)

Coronary atheroma composition and its association with segmental endothelial dysfunction in non-ST segment elevation myocardial infarction: novel insights with radiofrequency (iMAP) intravascular ultrasonography

The International Journal of Cardiovascular Imaging, 2015-02, Vol.31 (2), p.247-257

2015

Volltextzugriff (PDF)

Non-invasive volumetric assessment of aortic atheroma: a core laboratory validation using computed tomography angiography

International Journal of Cardiovascular Imaging, 2016-01, Vol.32 (1), p.121-129

2016

Volltextzugriff (PDF)

High-Density Lipoprotein: Is the Good Cholesterol Turning Bad?

Current cardiovascular risk reports, 2011-02, Vol.5 (1), p.18-28

2011

Volltextzugriff (PDF)

1 – 25 von 37

Suche als RSS-Feed

Aktive Filter

KollektionSpringerLINK Contemporary (Konsortium Baden-Württemberg)

Nur zeigenMit Volltextzugriff

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(37)

Publikationsform

Artikel
(37)

Sprache

Englisch
(37)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(31)
Science & Technology
(31)
Medicine
(28)
Medicine & Public Health
(28)
Cardiology
(24)
Cardiovascular System & Cardiology
(23)
Humans
(23)
Cardiac & Cardiovascular Systems
(18)
Atherosclerosis
(14)
Lipids
(9)
Risk Factors
(9)
Female
(8)
Male
(8)
Section Editor
(8)
Cardiovascular Diseases - Prevention & Control
(7)
Anticholesteremic Agents - Therapeutic Use
(6)
Imaging
(6)
Peripheral Vascular Disease
(6)
Aged
(5)
Angiology
(5)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

SpringerLink (Online service)
(37)
MEDLINE
(23)
WK Lippincott Williams & Wilkins–Connect here FIRST to enable access
(16)
Publisher or Other Site
(6)
IngentaConnect
(4)
Psychology & Behavioral Sciences Collection
(1)
IngentaConnect Journals
(1)
JSTOR
(1)

3 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Characterization of plaque phenotypes exhibiting an elevated pericoronary adipose tissue attenuation: insights from the REASSURE-NIRS registry

Clinical predictors and sequelae of computed tomography defined leaflet thrombosis following transcatheter aortic valve replacement at medium-term follow-up

ApoA-I Induction as a Potential Cardioprotective Strategy: Rationale for the SUSTAIN and ASSURE Studies

How Will Our Practice Change After the CLEAR Outcomes Trial?

The New Face of Hyperlipidemia and the Role of PCSK9 Inhibitors

CETP Inhibitors: Should We Continue to Pursue This Pathway?

Inflammation in Coronary Atherosclerosis and Its Therapeutic Implications

The Riskier Lipid: What Is on the HORIZON for Lipoprotein (a) and Should There Be Lp(a) Screening for All?

Elevated HDL-bound miR-181c-5p level is associated with diabetic vascular complications in Australian Aboriginal people

Assessing the Impact of Colchicine on Coronary Plaque Phenotype After Myocardial Infarction with Optical Coherence Tomography: Rationale and Design of the COCOMO-ACS Study

PCSK9 Inhibitors: Treating the Right Patients in Daily Practice

Calcified plaque harboring lipidic materials associates with no-reflow phenomenon after PCI in stable CAD

Lessons from Coronary Intravascular Ultrasound on the Importance of Raising High-Density Lipoprotein Cholesterol

CETP Inhibition in CVD Prevention: an Actual Appraisal

Evacetrapib

Update in Therapeutic Approaches to Plaque Stabilization

The Distinctive Nature of Atherosclerotic Vascular Disease in Diabetes: Pathophysiological and Morphological Insights

Atherosclerosis regression: is low-density lipoprotein or high-density lipoprotein the answer?

Apo A-I Modulating Therapies

Inhibition of secretory phospholipase A(2) in patients with acute coronary syndromes: rationale and design of the vascular inflammation suppression to treat acute coronary syndrome for 16 weeks (VISTA-16) trial

Statin Effects on Both Low-Density Lipoproteins and High-Density Lipoproteins: Is There a Dual Benefit?

Study Design, Rationale, and Baseline Characteristics: Evaluation of Fenofibric Acid on Carotid Intima-Media Thickness in Patients with Type IIb Dyslipidemia with Residual Risk in Addition to Atorvastatin Therapy (FIRST) Trial

Coronary atheroma composition and its association with segmental endothelial dysfunction in non-ST segment elevation myocardial infarction: novel insights with radiofrequency (iMAP) intravascular ultrasonography

Non-invasive volumetric assessment of aortic atheroma: a core laboratory validation using computed tomography angiography

High-Density Lipoprotein: Is the Good Cholesterol Turning Bad?

Aktive Filter

Suchergebnisse filtern